A prospective comparision of intranasal (IN) and subcutaneous (SC) desmopressin (DDAVP) therapy in type 2M Von Willebrand disease (VWD).

被引：0
|
作者：
Parameswaran, Rekha [1 ]
Shapiro, Amy D. [1 ]
Di Paola, Jorge [1 ]
Winay, Jon [1 ]
Roberson, Chris [1 ]
Greist, Anne [1 ]
机构：
[1] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1035
引用
收藏
页码：308A / 308A
页数：1
相关论文
共 50 条
  • [31] Von Willebrand disease type 2M: Correlation between genotype and phenotype
    Maas, Dominique P. M. S. M.
    Atiq, Ferdows
    Blijlevens, Nicole M. A.
    Brons, Paul P. T.
    Krouwel, Sandy
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Nieuwenhuizen, Laurens
    Schoormans, Selene C. M.
    Simons, Annet
    Meijer, Danielle
    van Heerde, Waander L.
    Schols, Saskia E. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (02) : 316 - 327
  • [32] Von Willebrand Disease Type 2M: Correlation Between Genotype and Phenotype
    Maas, D.
    Nijziel, M.
    Van Heerde, W.
    Schols, S.
    Laros-Van Gorkom, B.
    [J]. HAEMOPHILIA, 2017, 23 : 15 - 16
  • [33] Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients
    Federici, Augusto B.
    Iorio, Alfonso
    Castaman, Giancarlo
    [J]. BLOOD, 2010, 116 (21) : 110 - 111
  • [34] Intranasal administration of desmopressin (DDAVP) in hemophilia A and von Willebrand's disease: Evaluation of the efficacy and safety for the treatment at home of minor hemorrhage
    Derlon, A
    Goudemand, J
    Niez, P
    Gruel, Y
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 557 - 557
  • [35] POor response to 1-desamino-8-D arginine vasopressin (DDAVP) test in a patient with von Willebrand disease type 2M (VWD2M) with P.GLU1549LYS mutation
    Guglielmone, H.
    Frontroh, J.
    Minoldo, S.
    Hepner, M.
    Sabagh, M.
    Jarchum, G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 739 - 739
  • [36] Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor
    Hilbert, L
    Fressinaud, E
    Ribba, AS
    Meyer, D
    Mazurier, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (04) : 635 - 640
  • [37] von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M
    Baronciani, L.
    Federici, A. B.
    Cozzi, G.
    Canciani, M. T.
    Mannucci, P. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) : 2088 - 2090
  • [38] New insights into the diagnosis and management of patients with type 2M von Willebrand disease
    Iarossi, Michael
    Hermans, Cedric
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (07)
  • [39] Distinguishing types 1 and 2M von Willebrand disease
    Favaloro, E. J.
    Forsyth, C.
    Koutts, J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (01) : 102 - 105
  • [40] CHALLENGES IN DIAGNOSING TYPE 2M VON WILLEBRAND DISEASE: THE ROLE OF GENETIC TESTING
    Ksayer, R.
    Zakharia, K.
    Janbain, M.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 439 - 440
12345